President & Co-Founder of Troma Entertainment,American film Director, Producer, Actor, and Documentarian

LEGENDARY ENTERTAINMENT Acquires Rights To ‘The Toxic Avenger’

Long before superhero movies were the rage, and only Superman and Swamp Thing were out there saving the day, independent pioneers Lloyd Kaufman and Michael Herz gave us a 98 pound weakling who transformed into the first superhero…from New Jersey! The Toxic Avenger stormed onto the scene in 1984 and brought with it Troma’s trademark combination of over-the-top violence and gore and slapstick comedy, thus creating an empire. A big studio remake has been bandied about for years, but now we can exclusively announce Legendary Entertainment has acquired the feature film rights to The Toxic Avenger, with Kaufman and Herz producing.

The Toxic Avenger tells the story of Melvin, a janitor who works at a health club and gets picked on incessantly by the beefy, attractive, but completely mean patrons, until one day he’s pranked exceptionally hard and falls into a vat of toxic waste. The ensuing mutation turns him into a hideously deformed creature of superhuman size and strength–affectionately known as Toxie–who goes around Tromaville, NJ, cleaning up criminals and corrupt politicians in particularly unpleasant ways. But he’s a lovable hulking monster, at least.

Since its debut nearly 35 years ago, The Toxic Avenger has been one of the most successful cult franchises in history, spawning three sequels, a children’s cartoon in the ’90s, and even a live stage musical.

Troma Entertainment has cultivated a very specific brand of movie, a mix of horror, action, and raunchy comedy that has a fervent fan following. It’ll be interesting to see what a studio version of The Toxic Avenger would look like, and presuming it retains its edge, how much gore and gross-out humor it’ll be able to get away with and still receive an R-rating.

This entry was posted
on Saturday, December 15th, 2018 at 3:42 pm and is filed under News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.